MIDS Medical

MIDS Medical is a UK-based medical technology company specializing in the development of rapid point-of-care diagnostic solutions for infectious diseases and critical care. The company's core platform, the Microfluidic Integrated Diagnostic System (MIDS), utilizes advanced biosensors and microfluidics to deliver lab-quality results in minutes. Their primary focus is on addressing the global challenge of sepsis by providing clinicians with immediate data on biomarkers like Procalcitonin and C-reactive protein. By facilitating early diagnosis and targeted treatment, MIDS Medical aims to improve patient survival rates and combat antimicrobial resistance. The company is headquartered in London and maintains strong links with leading academic institutions to drive innovation in diagnostic technology.